Core Insights - The report indicates that as of October 23, 2025, institutional investors hold a total of 18.22 million shares of Hotgen Biotech (688068.SH), representing 19.65% of the company's total share capital, which is a decrease of 2.97 percentage points compared to the previous quarter [1] Group 1: Institutional Holdings - A total of 9 institutional investors have disclosed their holdings in Hotgen Biotech, with significant participants including Beijing Hotgen Biotech's repurchase account and various mutual funds [1] - The combined institutional holding percentage has decreased from the previous quarter, indicating a potential shift in investor sentiment [1] Group 2: Public Fund Holdings - Among public funds, 2 funds increased their holdings, accounting for a 0.76% increase, while 3 funds decreased their holdings, resulting in a 0.86% decrease [2] - A total of 284 public funds did not disclose their holdings this quarter, indicating a significant number of funds that may be reassessing their positions [2]
机构风向标 | 热景生物(688068)2025年三季度已披露前十大机构持股比例合计下跌2.97个百分点